By Devika Patel
Knoxville, Tenn., June 19 - AEterna Zentaris Inc. said it plans a $10 million registered direct offering of units.
The company will sell 5,319,149 common shares, with warrants for 1,861,702 additional shares, at $1.88 per unit of one common share and a half-share warrant. The warrants are each exercisable at $2.06 for 30 months.
Settlement is expected June 24.
Rodman & Renshaw, LLC is the agent.
Proceeds will be used for general corporate purposes.
AEterna Zentaris is a biopharmaceutical company focused on endocrine therapy and oncology based in Quebec City, Quebec.
| Issuer: | AEterna Zentaris Inc.
|
| Issue: | Units of one common share and a half-share warrant
|
| Amount: | $10 million
|
| Units: | 5,319,149
|
| Price: | $1.88
|
| Warrants: | For 1,861,702 shares
|
| Warrant expiration: | 30 months
|
| Warrant strike price: | $2.06
|
| Agent: | Rodman & Renshaw, LLC
|
| Pricing date: | June 19
|
| Settlement date: | June 24
|
| Stock symbol: | Nasdaq: AEZS
|
| Stock price: | $1.96 at close June 18
|
| Market capitalization: | $97.3 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
